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The hydrophobic effect (or the aggregated effects that we call “the hydrophobic effect”) 
underlies the binding of many ligands to proteins. It involves three molecular participants: the 
surface of the binding pocket of the protein, the surface of the ligand, and the networks of water 
molecules that fill the pocket and surround the ligand. The molecular-level mechanism of the 
hydrophobic effect in protein-ligand binding remains a subject of substantial controversy.
[1, 2] 
There are three primary questions of interest: i) “Do hydrophobic effects reflect the release of 
structured, and hence entropically unfavorable, water from hydrophobic surfaces when the ligand 
and surface of the binding pocket come into contact?”; ii) “Do hydrophobic effects represent the 
release of free-energetically unfavorable water from hydrogen-bonded networks in the binding 
pocket or displacement by the ligand, and the release of free-energetically unfavorable (although 
perhaps different) waters from the hydrophobic surface of the ligand?”; and iii) “How important 
in free energy are the contact interactions between the protein and the ligand in the binding 
pocket?”. 
In a previous examination of these questions,
[3] we compared the binding of a series of 
heteroarylsulfonamide ligands, and their “benzo-extended” analogs (Scheme 1), to human 
carbonic anhydrase II (HCA; EC 4.2.1.1). In these binding events, the addition of a benzo group: 
i) increased the hydrophobic surface area (and the volume) of the ligand; ii) generated two new 
van der Waals contacts between the ligand and hydrophobic wall of HCA; but iii) did not result 
in a significant increase in the area of contact between the hydrophobic surfaces of the protein 
and ligand. The free energy of binding of the arylsulfonamide ligands increased with the 
additional surface area buried upon binding from the benzo-extension by −20 cal mol
1Å
2,
[3] an 
amount expected for normal hydrophobic effects (−20 to –33 cal mol
1Å
2)
[4]. The heat capacity 
of binding (∆Cp
o) of the benzo-extended ligands was more negative than the corresponding  
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Scheme 1. Arylsulfonamide ligands. Hydrophobic surface area is added to the heterocyclic 
ligands by: a “benzo-extension”, denoted with a H4; a “fluorobenzo-extension”, denoted with a 
F4; or a “tetrahydrobenzo-extension”, denoted with a H8. The bold letters are the ligand 
acronyms: (B)TA = (benzo)thiazole; (B)T = (benzo)thiophene; (B)P = (benzo)pyrrole; (B)MP = 
N-methyl(benzo)pyrrole. 
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arylsulfonamide
[3]—a change commonly considered to be a sign of a hydrophobic interaction.
[5] 
We drew two conclusions pertinent to protein-ligand interactions from the previous study:
[3] 
i) the balance of enthalpy and entropy responsible for the differences in the partitioning of a 
ligand, and its benzo-extended analog, between octanol and buffer is not the same as that 
responsible for differences in the binding of these ligands to HCA; and ii) the increased binding 
affinity of the benzo-extended ligands to HCA results from an increased favorability in the 
enthalpy of binding, and not from an increased entropy of binding. The enthalpy-driven binding 
observed between these ligands and HCA is not compatible with the mechanism of the 
hydrophobic effect proposed by Kauzmann and Tanford (KT),
[4, 6] but is similar to those 
observed in other protein-ligand systems.
[7-9] We—along with Berne,
[10] Chandler,
[11] Friesner,
[12, 
13] Klebe,
[14] Ladbury,
[15, 16] Lemieux,
[17] Rossky,
[18, 19] and Toone
[20, 21]—attribute this type of 
enthalpy-dominated hydrophobic effect to the release of water from the binding pocket upon 
binding of the ligand. Similar thermodynamic signatures characterize binding of the benzo and 
the tetrahydrobenzo derivative of T (see Scheme 1).
[3] 
The objective of this work was to determine if replacing the four C – H bonds of the benzo 
moiety with four C – F bonds (i.e., “fluorobenzo-extension”) would change the hydrophobic 
interactions of these ligands with HCA. Fluorocarbons are commonly believed to be “more 
hydrophobic” than homologous hydrocarbons,
[22, 23] but typical measures of hydrophobicity—
when corrected for differences in surface area—are very similar, if not indistinguishable.
[9, 23, 24] 
We measured the partitioning of the benzo- and fluorobenzo-extended ligands between buffer 
and octanol, and found the surface area-corrected hydrophobicity of the ligands increases (by ~ 
1.1 cal mol
1 Å
2) upon fluorination (summarized in the Supporting Information (SI)).  
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Benzo- and fluorobenzo-extended ligands bind to HCA with similar geometry. Crystal 
structures of HCA complexed with F4BTA, H4BTA, and H8BTA (Figure 1) show that the 
geometry of binding of these ligands is similar in orientation despite their differences in shape, 
volume, and surface. The geometries of binding of F4BT, H4BT, and H8BT are also conserved 
(see SI). 
Careful inspection of the crystal structures of H4BTA and F4BTA reveals that fluorination of 
the ligand shifts its position within the binding pocket by 0.7 Å (Figure 1D) while the positions 
of the side chains of the amino acids lining the binding pocket of HCA do not change. We 
attribute this shift of F4BTA to an increased number of unfavorable interactions between the 
ligand and the binding pocket (Figure 1E); in particular, the Coulombic repulsion between the 
fluorine atom on the ligand and the carbonyl of Thr 200,
[25] a 3.0 Å distance. 
The atomic composition of the benzo-extension does not affect binding affinity. We 
measured the enthalpies of binding (∆H
o
bind) and the association constants (Ka) for the series of 
ligands in Scheme 1 using isothermal titration calorimetry (ITC), and estimated the free energies 
(∆G
o
bind) and entropies (−T∆S
o
bind) of binding. To account for differences in the pKa of each 
ligand, we corrected the measured thermodynamic parameters to represent the binding of the 
sulfonamide anion to HCA (details in the SI).
[26] 
Remarkably, values of ∆G
o
bind of the benzo- and fluorobenzo-extended compounds are 
indistinguishable at a 90% confidence level (Figure 2A). Values of ∆G
o
bind, combined with the 
overall conserved binding geometry of each set of benzo- and fluorobenzo-extended ligands  
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Figure 1. Crystal structures of the active site of HCA complexed with A) H4BTA, B) F4BTA, 
and C) H8BTA. The Zn
+2 ion is represented by a purple sphere in each structure. D) An overlay 
of the heavy atoms of the H4BTA (blue) and F4BTA (green) ligands from aligned crystal 
structures. Diagrams of the amino acid residues in contact with the E) benzo-extended portion of 
H4BTA, and F) the fluorobenzo-extended portion of F4BTA. Favorable interactions between the 
ligand and the protein are represented with a blue dashed line, and unfavorable interactions with 
a red dashed line.  
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suggests that binding depends on a fine balance of interactions between HCA, the ligand, and molecules of water 
filling the pocket and surrounding the ligand, and that a simple analysis of interactions between the protein and 
ligand (Figure 1E), or of the physiochemical properties of the ligands, is insufficient to understand (or more 
importantly, predict) the energetics of binding. Our previous study of H4BT and H8BT showed that changes in the 
shape of the ligand also resulted in indistinguishable values of ∆G
o
bind.
[3] 
The increased binding affinity of TA (or T) upon benzo- and fluorobenzo-extension is an 
enthalpy-dominated hydrophobic interaction, and not the “classical hydrophobic” effect 
described by KT. We showed previously that the interactions between the benzo-extended 
ligands and HCA do not result from a “non-classical hydrophobic effect”,
[27] because the binding 
of H8BT is also enthalpy-dominated.
[3] The partitioning of H4BTA and F4BTA from buffer into 
octanol (Figure 2B) is, however, an entropy-dominated hydrophobic effect, and in agreement 
with the KT model. 
The release of water from the binding pocket, and not contact between the protein and 
ligand, affects binding affinity. Comparisons of the crystal structures of H4BMP and H4BTA 
(or F4BMP and F4BTA, Figure 3) show that the positions of the side chains of the amino acids 
lining the binding pocket of HCA do not change, even when the geometry of the bound ligand 
shifts significantly. The root-mean square deviation for the heavy atoms of the protein in the 
aligned structures is 0.185 Å for H4BMP and H4BTA, 0.214 Å for F4BMP and F4BTA, and (for 
comparison) 0.200 Å for H4BTA and F4BTA.  
The values of ∆G
o
bind for H4BMP and F4BMP are also indistinguishable (∆∆G
o
bind = 0.7 ± 
0.1 kcal mol
-1), and enthalpy-dominated. These results support our hypothesis that the increased 
binding affinity of the benzo-extended ligands is independent of the change in atomic  
  
Page 8 of 34 
 
Figure 2. A) Thermodynamics of binding of the anion of each arylsulfonamide ligand to HCA as 
a function of the difference in solvent-accessible surface area between the bound and unbound 
states of the ligand. Each datum is the average of at least seven independent measurements, and 
the error bars represent one standard deviation from the mean (many of the error bars for the 
values of ∆G
o
bind are too small to distinguish). B) Thermodynamics of partitioning of H4BTA 
and F4BTA from buffer to octanol; each datum is the average of three independent 
measurements. The equilibrium constants for partitioning from octanol to buffer of each 
sulfonamide were measured by a shake-flask method. Values for the enthalpy of partitioning of 
each ligand represent the difference between the enthalpy of dissolution into buffer and the  
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enthalpy of dissolution into octanol. Values for the thermodynamics of partitioning and binding 
are corrected for the ionization of the sulfonamide group in the buffer phase.
[3] 
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composition of the benzo group, and almost indistinguishable for three types of functional 
groups that have very different molecular properties.  
While the ∆G
o
bind is unchanged upon fluorination, we observe significant and compensating 
changes in ∆H
o
bind and –T∆S
o
bind (Figure 2A). To elucidate potential sources for the differences in 
the ∆H
o
bind and –T∆S
o
bind we calculated the molecular mechanics implicit solvent binding energy 
(with Prime MM-GBSA calculations
[28]) of H4BTA and F4BTA, and decomposed these values 
into individual energetic components (i.e., Coulombic, van der Waals, desolvation, ligand strain, 
etc.). The differences between the individual components of the binding energy of H4BTA and 
F4BTA are similar (less than 1.5 kcal mol
-1 different, see SI) except for: the Coulombic term, 
which favors the binding of H4BTA by 5.8 kcal mol
-1; and the desolvation term, which favors the 
binding of F4BTA by 8.2 kcal mol
-1. 
The crystal structures of H4BTA and F4BTA (Figure 1E) support the improved Coulombic 
interactions between H4BTA and the binding pocket of HCA; this picture is further supported by 
the more favorable H
o
bind of H4BTA over F4BTA. The desolvation of F4BTA is more favorable 
than H4BTA, and is consistent with the values of –TS
o
bind (Figure 2A) and free energy and 
entropy of partitioning (Figure 2B) of both ligands. The free energy of desolvation of the ligand 
is a primary contributor, along with conformational energy, to the –TS
o
bind associated with 
protein-ligand binding.
[29] We assume the role of the conformational entropy in the HCA-ligand 
complexes is minimal because of the rigidity of the binding pocket of HCA and the conserved 
binding geometry of each ligand; this rigidity stems from the fact that there is only a single, 
rotatable bond (the Ar-SO2NH
- bond) in the molecule. 
 The Prime MM-GBSA calculations predict a more favorable total free energy of binding of 
HCA with F4BTA over H4BTA (by < 3.0 kcal mol
-1). The zero-temperature model used in MM- 
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GBSA calculations, however, tend to overestimate the predicted magnitude of G
o
bind (by ~3-
fold
[30]). The adjusted value of G
o
bind for the MM-GBSA calculations is within the experimental 
error of our ITC measurements, and agrees (qualitatively) with the indistinguishable values of 
G
o
bind we measured for H4BTA and F4BTA.  
Different benzo-extensions cause similar effects on the water molecules inside the protein 
pocket upon binding. Crystal structures of HCA complexed with H4BTA or F4BTA show that 
fluorination of the benzo-extended ligands increases the number of localized (i.e., 
crystallographically resolvable) waters in the binding pocket of HCA from six to ten. We 
summarize the number of fixed molecules of water for the benzo- and fluorobenzo-extended 
BTA and BMP ligands in Table 1. This result mirrors our previous study,
[3] which showed that 
the addition of the benzo-extension to the arylsulfonamide ligands increased the number of fixed 
waters within the binding pocket of HCA. The number of waters localized by the benzo-extended 
ligands cannot be attributed solely to the surface area of the ligand—H4BTA = 448 Å
2, F4BTA = 
483 Å
2—because H8BTA (470 Å
2) has a larger surface area than H4BTA, but localizes a smaller 
number of waters (SI). 
We measured values of ∆H
o
bind of TA, H4BTA, and F4BTA over a temperature range of  288 
− 307 K, plotted ∆H
o
bind as a function of temperature, and applied a linear fit to each set of data 
to determine the heat capacity of binding (∆C
o
p) for each ligand: TA = −13 cal mol
−1 K
−1, 
H4BTA = −64 cal mol
−1 K
−1, and F4BTA = −108 cal mol
−1 K
−1. The ∆C
o
p of each ligand is 
negative, and is compatible with our hypothesis that the interaction between the ligand and the 
protein is hydrophobic in nature.
[5]  
The difference in the heat capacity of F4BTA and H4BTA (∆∆C
o
p = ∆C
o
p(F4BTA) − ∆C
o
p 
(H4BTA) = −44 cal mol
−1 K
−1) is much larger than the difference calculated from the buried,  
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Figure 3. Side-by-side comparison the active site of HCA complexed with (F)BTA (blue) and 
(F)BMP (orange). A) H4BTA and H4BMP and B) F4BTA and F4BMP. 
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non-polar surface area of the two ligands (−19 cal mol
−1 K
−1).
[5] We attribute this discrepancy 
between the measured and predicted values of ∆C
o
p to the additional “fixed” waters observed in 
the crystal of F4BTA bound to HCA (Figure 1D). The value estimated by Connelly for the 
ordering of a single water (−9 cal mol
−1 K
−1)
[31] suggests that three additional molecules of 
water are fixed in the binding pocket of HCA when the hydrogen atoms of H4BTA are replaced 
with fluorine atoms, and is consistent with the four additional waters observed in the crystal 
structure.  
Increases in binding affinity of ligands correlates with the number of waters released from 
the binding pocket of HCA, and not with the atomic composition or structure of the ligand. 
The calorimetry and X-ray crystallography data for the binding of benzo- and fluorobenzo-
extended arylsulfonamide ligands to HCA reinforce our previous conclusion:
[3] the hydrophobic 
effect involved in the binding of arylsulfonamide ligands to HCA is not dominated by a direct 
interaction between the hydrophobic surfaces of the protein and the ligand, but is a result of a 
more general interaction in which the non-polar ligand displaces free-energetically unfavorable 
waters from the binding pocket into the bulk. 
 The ∆G
o
bind of these ligands is independent of both the orientation of the ligand in the 
binding pocket of HCA, and the atoms in the benzo-extension as both ligands displace a similar 
number of water molecules from the binding pocket. The addition of a benzo-extension to the 
heterocyclic sulfonamide ligand results in a favorable increase in ∆H
o
bind; the model proposed by 
KT does not explain the binding of these ligands to HCA, but is compatible with their 
partitioning between buffer and octanol. Replacing the four hydrogen atoms of the benzo-
extension with fluorine atoms does result, however, in a decreased favorability of ∆H
o
bind and an 
increased favorability of –T∆S
o
bind. The compensation of ∆H
o
bind and –T∆S
o
bind can be  
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rationalized in terms of the Coulombic interactions of each ligand with the binding pocket of 
HCA (i.e., the ∆H
o
bind term) and the changes in the energy of solvation (i.e., the –T∆S
o
bind term) 
of the benzo-extended ligand upon fluorination. 
These differences in the thermodynamics of partitioning of these ligands from buffer to 
octanol, and from buffer to the binding pocket of HCA, support the idea that there is not a single 
hydrophobic effect reflecting release of water from contacting surfaces of HCA and ligand, but 
rather aggregated hydrophobic effects that are dependent on the structure of water in the binding 
pocket of HCA, and on the structure of water surrounding the ligand. 
 
Supporting Information for this article is available on the WWW under 
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Table 1. Summary of thermodynamic and structural data for the thiazole and methyl-
pyrrole ligands 
Ligand  H4BTA  F4BTA  H4BMP  F4BMP 
ΔG
o
bind [kcal mol
-1]  –13. 5 ± 0.4  –13.0 ± 0.2  –13.2 ± 0.1  –13.3 ± 0.1 
ΔΔG  | --- Indistinguishable --- |  | --- Indistinguishable --- | 
ΔH
o
bind [kcal mol
-1]  –18.9 ± 0.5  –16.3 ± 0.6  –12.4 ± 0.5  –8.4 ± 0.6 
−TΔS
o
bind [kcal mol
-1]   5.5 ± 0.7   3.4 ± 0.5  –0.7 ± 0.5  –4.8 ± 0.7 
∆∆C
o
p [cal mol
-1]
a  | ---            –44            --- |  Not measured 
Fixed waters
b  6  10  4  7 
ΔGeometry (relative to 
H4BTA) 
---  Translation (0.7 Å)
c  Rotation (27
o)
d  Rotation (31
o)
d 
         
 
 
a ∆∆C
o
p = ∆C
o
p(F4BTA) − ∆C
o
p(H4BTA) 
b Obtained from crystal structures of HCA-ligand complex. 
c Ligand moves in the direction of Gln 92. 
d Rotation along the long axis of the ligand.  
Page 16 of 34 
Supporting Information for this article are available on the WWW under 
http://dx.doi.org/10.1002/anie.XXXXXXXX.  
 
Acknowledgements. The authors thank Dr. Jasmin Mecinovic, Dr. Ramani Ranatunge, Dr. 
Demetri Moustakas, Dr. Manza Atkinson, Dr. Mohammad Al-Sayah, Dr. Shuji Fujita, and Mr. 
Jang Hoon Yoon for their technical contributions. This work was supported by the National 
Science Foundation (CHE-1152196) and the Wyss Institute of Biologically Inspired 
Engineering. H.L. thanks the Deutsche Forschungsgemeinschaft (DFG) for a postdoctoral 
research stipend.  
Page 17 of 34 
References. 
[1]  W. Blokzijl, J. B. F. N. Engberts, Angew. Chem., Int. Ed. 1993, 32, 1545. 
[2]  N. T. Southall, K. A. Dill, A. D. J. Haymet, J. Phys. Chem. B 2002, 106, 521. 
[3]  P. W. Snyder, J. Mecinovic, D. T. Moustakas, S. W. Thomas, M. Harder, E. T. Mack, M. 
R. Lockett, A. Heroux, W. Sherman, G. M. Whitesides, Proc. Nat. Acad. Sci., U.S.A. 
2011, 108, 17889. 
[4]  C. Tanford, Proc. Nat. Acad. Sci., U.S.A. 1979, 76, 4175. 
[5]  N. V. Prabhu, K. A. Sharp, Ann. Rev. Phys. Chem. 2005, 56, 521. 
[6]  W. Kauzmann, Ann. Rev. Phys. Chem. 1957, 8, 413. 
[7]  W. P. Jencks, Catalysis in Chemistry and Enzymology, McGraw-Hill, New York, New 
York, 1969. 
[8]  S. W. Homans, Drug Discov. Today 2007, 12, 534. 
[9]  J. Mecinovic, P. W. Snyder, K. A. Mirica, S. Bai, E. T. Mack, R. L. Kwant, D. T. 
Moustakas, A. Heroux, G. M. Whitesides, J. Am. Chem. Soc. 2011, 133, 14017. 
[10]  B. J. Berne, J. D. Weeks, R. Zhou, Ann. Rev. Phys. Chem. 2009, 60, 85. 
[11]  K. Lum, D. Chandler, J. D. Weeks, J. Phys. Chem. B 1999, 103, 4570. 
[12]  R. Chakrabarti, A. Klibanov, R. Friesner, Proc. Nat. Acad. Sci., U.S.A. 2005, 102, 10153. 
[13]  R. Abel, T. Young, R. Farid, B. Berne, R. Friesner, J. Am. Chem. Soc. 2008, 130, 2817. 
[14]  A. Biela, N. N. Nasief, M. Betz, A. Heine, D. Hangauer, G. Klebe, Angew. Chem., Int. 
Ed. 2013, 52, 1. 
[15]  T. S. G. Olsson, J. E. Ladbury, W. R. Pitt, Protein Sci. 2011, 20, 1607. 
[16]  T. S. G. Olsson, M. A. Williams, W. R. Pitt, J. E. Ladbury, J. Mol. Biol. 2008, 384, 1002. 
[17]  R. U. Lemieux, Acc. Chem. Res. 1996, 29, 373. 
[18]  N. Giovambattista, C. F. Lopez, P. J. Rossky, P. G. Debenedetti, Proc. Nat. Acad. Sci., 
U.S.A. 2008, 105, 2274. 
[19]  P. J. Rossky, M. Karplus, J. Am. Chem. Soc. 1979, 101, 1913. 
[20]  M. C. Chervenak, E. J. Toone, J. Am. Chem. Soc. 1994, 116, 10533. 
[21]  T. G. Oas, E. J. Toone, Adv. Biophys. Chem. 1997, 6, 1. 
[22]  J. D. Dunitz, ChemBioChem 2004, 5, 614. 
[23]  M. Salwiczek, E. K. Nyakatura, U. I. M. Gerling, S. Ye, B. Koksch, Chem. Soc. Rev. 
2012, 41, 2135. 
[24]  J. C. Biffinger, H. W. Kim, S. G. DiMagno, ChemBioChem 2004, 5, 622. 
[25]  A. Bondi, J. Phys. Chem. 1964, 68, 441. 
[26]  V. M. Krishnamurthy, G. K. Kaufman, A. R. Urbach, I. Gitlin, K. L. Gudiksen, D. B. 
Weibel, G. M. Whitesides, Chem. Rev. 2008, 108, 946. 
[27]  E. A. Meyer, R. K. Castellano, F. Diederich, Angew. Chem., Int. Ed. 2003, 42, 1210. 
[28]  P. D. Lyne, M. L. Lamb, J. C. Saeh, J. Med. Chem. 2006, 49, 4805. 
[29]  E. Freire, Drug Discov. Today 2008, 13, 869. 
[30]  R. Abel, N. K. Salam, J. Shelley, R. Farid, R. A. Friesner, W. Sherman, ChemMedChem 
2011, 6, 1049. 
[31]  P. R. Connelly, Structure-Based Drug Design: Thermodynamics, Modeling and Strategy, 
Springer, Berlin, 1997. 
 
    
Page 18 of 34 
SUPPORTING INFORMATION 
 
 
The Binding of Benzoarylsulfonamide Ligands to Human Carbonic 
Anhydrase is Insensitive to Formal Fluorination of the Ligands  
 
Heiko Lange,
a,† Matthew R. Lockett,
a,† Benjamin Breiten,
a Annie Heroux,
b Woody Sherman,
c 
Dmitrij Rappoport,
a Patricia O. Yau,
a Philip W. Snyder,
a  
George M. Whitesides
a,d,* 
 
 
a Department of Chemistry and Chemical Biology, Harvard University 
12 Oxford Street, Cambridge, MA 02138 
b National Synchrotron Light Source, Brookhaven National Laboratory 
725 Brookhaven Avenue, Upton, NY 11973-5000 
c Schrödinger Inc.,  
120 West 45
th Street, New York, NY 10036-4041 
d Wyss Institute for Biologically Inspired Engineering, Harvard University 
60 Oxford Street, Cambridge, MA 02138 
 
  
Page 19 of 34 
Expression and Purification of Human Carbonic Anhydrase 
We chose human carbonic anhydrase II (HCA, E.C. 4.2.1.1) as a model protein to study the 
hydrophobic effect in protein-ligand binding, because HCA: i) is well-characterized 
structurally,
[1] and has a binding pocket comprised of a distinct “hydrophobic wall” and a distinct 
“hydrophilic wall”;
[1] ii) is structurally rigid, and retains its secondary and tertiary structure upon 
binding of a ligand;
[1, 2] iii) can be expressed in E. coli in the quantities necessary for calorimetry 
experiments and X-ray crystallography; iv) crystallizes readily, and the conditions for growing 
crystals, reproducibly, are known.
[3] 
We expressed HCA in BL21(DE3)pLysS competent cells (Promega, Madison, WI), 
transformed with a pACA plasmid containing the HCA gene,
[4][5] according to the procedures 
published by Fierke and coworkers.
[5] After expression, the cultures of E. coli were pelleted (20 
min, 10,000 x g, 4 
oC), flash frozen under liquid nitrogen, and stored at –80 
oC until needed. 
We lysed the E. coli with BPER protein extraction buffer (Thermo Scientific) augmented 
with: MgSO4 (1 mM), N-p-tosyl-L-arginine methyl ester (TAME, 1 mM), tris(2-
carboxyethyl)phosphine (TCEP, 3 mM), ZnSO4 (2.5 mM), phenylmethanesulfonyl fluoride 
(PMSF, 1 µM), lysozyme (0.125 µg / mL), and DNase I (10 U / mL). The HCA was precipitated 
from the cellular lysate with ammonium sulfate (60% v/v with a solution of saturated ammonium 
sulfate), and then dialyzed into Tris-SO4 buffer (50 mM, pH = 8.0) containing ZnSO4 (200 µM) 
and TCEP (200 µM). The dialyzed protein was further purified on an AKTA purifier (GE 
Healthcare) with: i) anion exchange chromatography with Q Sepharose Fast Flow resin (Sigma 
Aldrich); and ii) size exclusion chromatography with SuperDex 75 resin (GE Healthcare). We 
used Tris-SO4 buffer (50 mM, pH = 8.0) containing ZnSO4 (200 µM) and TCEP (200 µM) for all 
chromatographic separations.  
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Synthesis of the Heteroarylsulfonamide Ligands 
We synthesized the benzo- and fluorobenzo-extended ligands from commercially available 
starting materials, which we used without further purification (Sigma Aldrich, Alfa Aesar, TCI, 
and 3B Scientific Corporation). We characterized the final product of each synthesis with 
1H and 
19F NMR spectroscopy, and GC-MS (EI). We measured
 1H and 
19F spectra on a 300 or 400 MHz 
instrument, and report the chemical shifts (in ppm) relative to tetramethylsilane for 
1H NMR 
spectra, and relative to trichloro-fluoromethane for 
19F NMR spectra. Coupling constants (J) are 
given in Hz, and the apparent resonance multiplicities are abbreviated with (b)s ((broad) singlet), 
d (doublet), t (triplet), and m (multiplet). We measured the mass of each compound with an 
Agilent GC/MSD 5975A inert with a Triple-Axis Detector, controlled via Agilent GC 
ChemStation Software (version E.02.00.493), containing a HP 5MS column (5% diphenyl 95% 
dimethylpolysiloxane, 30 m x 0.25 mm).  
We synthesized the benzo-extended ligands according to previously published synthetic 
procedures: benzo[b]thiophene-2-sulfonamide (H4BT),
[6] benzo[d]thiazole-2-sulfonamide 
(H4BTA),
[6] 1H-indole-2-sulfonamide (H4BP),
[7] 1-methyl-1H-indole-2-sulfonamide 
(H4MBP),
[8] 4,5,6,7-tetrahydrobenzo[b]thiophene-2-sulfonamide (H8BT),
[9] and 4,5,6,7-
tetrahydrobenzo[d]thiazole-2-sulfonamide (H8BTA).
[10] We stored all ligands under argon or 
nitrogen at room temperature. 
General Synthetic Procedure for Fluorobenzo-extended Ligands. If not stated otherwise, 
the fluorobenzo-extended ligands were synthesized following a general synthetic procedure (GP) 
developed by Chern et al.
[6] The starting material (typically 10 mmol, 1 equiv.) was dissolved in 
dry tetrahydrofuran (THF) under an argon atmosphere, cooled to 78° C, and reacted with a 1.6 
M solution of n-butyllithium in hexanes (1.1 equiv.). The reaction mixture was stirred for 1 hour,  
Page 21 of 34 
and allowed to warm to ca. 0° C before the intermediate aryl lithium species was quenched with 
dry gaseous sulfur dioxide. Sulfur dioxide was blown over the surface of the reaction solution for 
approximately five minutes to exchange the atmosphere in the flask, and the flask re-sealed with 
a balloon filled with gaseous sulfur dioxide. The reaction mixture was stirred for an additional 
hour, and the reaction mixture was allowed to warm to room temperature. Argon was then 
bubbled through the reaction suspension to remove the excess of sulfur dioxide, and the resulting 
slurry was concentrated in vacuo to yield the lithium benzoaryl-2-sulfinate as a pasty solid.  
The crude lithium sulfinates were re-dissolved in aqueous sodium acetate, hydroxylamine-O-
sulfonic acid (2.5 equiv.) was added at 0° C, and the mixture stirred overnight at room 
temperature. The precipitate was isolated by filtration, washed with cold water, and the 
fluorobenzo-extended ligands recrystallized.  
4,5,6,7-tetrafluorobenzo[b]thiophene-2-sulfonamide (F4BT). F4BT was synthesized, 
according to the general procedure (GP) outlined above, from 4,5,6,7-
tetrafluorobenzo[b]thiophene, which was prepared from 4,5,6,7-tetrafluorobenzo[b]thiophen-2-
carboxylic acid
[11] using a copper-catalyzed decarboxylation described previously.
[12] 
1H NMR (300 MHz, DMSO-d6) δ 8.17 (bs, 2H), 7.54 (s, 1H); 
19F NMR (282 MHz, DMSO-
d6) δ 137.5 (dd, J = 14.4, 21.4), 147.0 (dd, J = 14.8, 20.8), 155.7 (t, J = 21.3), 156.4 (t, J = 
20.8); GC-MS (EI, 70 eV): m/z 284.9 (M
+, 100%) @ tR 21.8 min. 
4,5,6,7-tetrafluorobenzo[d]thiazole-2-sulfonamide (F4BTA). F4BTA was prepared from 
2,3,4,5,6-pentafluoroaniline, which was prepared from 4,5,6,7-tetrafluorobenzo[d]thiazole-2-
thione.
[13] The thione was reacted with an aqueous solution of ammonia in the presence of 
sodium hydroxide and sodium hypochlorite to yield the intermediate S- 
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(perfluorobenzo[d]thiazol-2-yl)thiohydroxylamine.
[14] The latter was isolated and treated with 
hydrogen peroxide solution to furnish F4BTA after re-crystallization.  
1H NMR (300 MHz, DMSO-d6) δ 8.68 (bs, 2H); 
19F NMR (282 MHz, DMSO-d6) δ 137.5 
(dd, J = 14.4, 21.4), 147.0 (dd, J = 14.8, 20.8), 155.7 (t, J = 21.3), 156.4 (t,  
J = 20.8); GC-MS (EI, 70 eV): m/z 268.9 ([M  H2O]
+, 100%) @ tR 13.0 min. 
4,5,6,7-tetrafluorobenzo[b]-1H-pyrrole-2-sulfonamide (F4BP). F4BP was synthesized from 
4,5,6,7-tetrafluoro-1H-indole according to the GP outlined above, after the indole-nitrogen was 
protected with a benzoyl group according to standard protocols.
[6] The final product was 
deprotected according to standard protocols.
[6] 
1H NMR (300 MHz, DMSO-d6) δ 7.81 (bs, 2H), 7.10 (s, 1H), 3.35 (bs, ca.1H);
 19F NMR 
(282 MHz, DMSO-d6) δ 149.4 (dd, J = 17.2, 21.0), 157.6 (dd, J = 17.1, 20.3), 163.5 (t, J = 
20.4), 169.0 (dt, J = 21.0, 3.4); GC-MS (EI, 70 eV): m/z 268.0 (M
+, 100%) @ tR 21.2 min. 
4,5,6,7-tetrafluorobenzo[b]-N-methyl-pyrrole-2-sulfonamide (F4MBP). F4MBP was 
synthesized from 4,5,6,7-tetrafluoro-N-methyl-indole, according to the GP outlined above, 
which was obtained by the methylation of 4,5,6,7-tetrafluoro-1H-indole with methyl iodide in 
the presence of sodium hydride in dry THF.
[6] 
1H NMR (300 MHz, DMSO-d6) δ 8.14 (bs, 2H), 7.10 (s, 1H), 3.31 (s, 3H);
 19F NMR (282 
MHz, DMSO-d6) δ 149.6 (dd, J = 16.8, 20.9), 161.9 (t(dd), J = 20.8), 162.9 (t,  
J = 20.7), 169.0 (dt, J = 21.1, 3.8); GC-MS (EI, 70 eV): m/z 282.0 (M
+, 100%) @ tR 20.3 min. 
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Physiochemical Characterization of the Heteroarylsulfonamide Ligands 
We summarize the physico-chemical data collected for each sulfonamide ligand in Table S1, 
and discuss the procedures in detail below. 
Determination of pKa. The pKa of T, TA, H4BT, H8BT, and H4BTA (Figure S1) were 
determined previously.
[2] We used the same procedure to determine the pKa of the fluorobenzo-
extended ligands: a solution of the ligand (20 mM in DMSO) was added to a buffered solution 
(10 mM, ranging from pH 1 to pH 13 in 0.5 increments of pH) in a cuvette, and a UV-VIS 
spectrum obtained.  
Determination of H
o
ion. We could not measure the H
o
ion of the fluorobenzo-extended 
ligands directly with calorimetry due to their low solubility. To approximate values of H
o
ion, we 
correlated the chemical shift of the proton in the sulfonamide group, measured with 
1H NMR 
spectroscopy, with the chemical shift of the proton in the sulfonamide group of known 
heteroarylsulfonamide ligands (Figure S1) – namely thiophene-2-sulfonamide (T), 
benzothiophene-2-sulfonamide (H4BT), thiazole-2-sulfonamide (TA), benzothiazole-2-
sulfonamide (H4BTA), furane-2-sulfonamide (F), benzofurane-2-sulfonamide (H4BF), 
imidazole-2-sulfonamide (I), benzoimidazole-2-sulfonamide (H4BI), benzopyrrole-2-
sulfonamide (H4BP). 
Partitioning experiments. We measured the equilibrium constant of partitioning, between 
sodium phosphate buffer (10 mM, pH = 7.6) and octanol, for each of the benzo- and fluorobenzo-
extended ligands using the shake-flask method described previously.
[2] 
Solution calorimetry. We followed the procedure reported previously,
[2] and measured the 
heat of dissolution for solid samples of each ligand (5–10 mg) with a TAMIII calorimeter (TA 
Instruments).  
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Table S1. Physico-chemical properties of the heteroarylsulfonamide ligands, and the Zn(II)-
bound-water form of HCA II (HCA-Zn(II)-OH2
+), used in this study. 
 
system 
   ligand 
SASA 
[Å
2] 
pKa 
 
 
ΔH°ion 
[kcal 
mol
1]
 a 
logP 
b  G°OW 
 
[kcal 
mol
1]
G°OW  
per Å
2 
[cal mol
1 
Å
2] 
thiophene             
   T  301  9.6    8.4    1.62    0.8 ± 0.04    2.7 
   H4BT  369  9.5    8.1    0.76    1.6 ± 0.1    .3 
   F4BT  380  8.6    7.8  0.44    2.0 ± 0.3    5.3 
   H8BT  394  9.8 
c    8.5   n.d.     n.d.     n.d.    
               
thiazole             
   TA  296  8.4    7.7    1.46  0.8 ± 0.03  2.7 
   H4BTA  364  8.2    7.4  0.25    1.3 ± 0.3    3.6 
   F4BTA  379  7.9     7.2  1.33    2.5 ± 0.1    6.6 
   H8BTA  391  n.d.  n.d.     n.d.     n.d.     n.d.    
               
pyrrole               
   H4BP  366  9.8    8.5    1.12    1.5 ± 0.2    4.1 
   F4BP  377  9.4    8.2    0.11    2.3 ± 0.1    6.1 
               
N-methyl pyrrole               
   H4MBP  384  9.4    8.2    0.65    1.6 ± 0.3    4.1 
   F4MBP  402  8.8    7.8   -0.12    1.8 ± 0.6    4.5 
               
               
protein               
   HCA-Zn(II)-OH2
+ d   n.d.  6.9    (6.9)    6.9  ---  ---  --- 
 
a)  NMR experiments were performed in DMSO-d6 at 25° C.  
b)  Calculated via logP = logD + log(1 + 10
pKa-pH). 
c)  Determined previously by Snyder et al.
[2] 
d)  Values estimated according to the literature.
[1] 
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Figure S1. NMR-based approximation of values of ΔH°ion for the fluorobenzo-extended ligands. 
The solid black circles represent an independently measured value of ΔH°ion for the fluorobenzo-
extended ligands. The hollow circles represent an independently measured value of ΔH°ion from 
compounds for which ΔH°ion had been independently determined, and reported
[2]: I – imidazole-
2-sulfonamide, H4BP – benzo[b]pyrrole-2-sulfonamide, T – thiophene-2-sulfonamide, F – 
furane-2-sulfonamide, H4BT – benzo[b]thiophene-2-sulfonamide, H4BF – benzo[b]furane-2-
sulfonamide, H4BTA – benzo[d]thiazole-2-sulfonamide We correlated the chemical shift of the 
sulfonamide proton to obtain the linear curves displayed.  
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Isothermal Titration Calorimetry 
We conducted all ITC experiments on an Auto VP-ITC instrument (Microcal). In each 
titration experiment, 19 injections of ligand (7.8 µL, 100 µM) were introduced into the 
calorimeter cell, which contained HCA (1.6 mL, 100 µM), and the heat of binding (H
o
bind) was 
recorded. We used sodium phosphate buffer (10 mM, pH = 7.60) for all experiments. 
The raw data were analyzed using the Origin software package, and the free energy of 
binding (G
o
bind) and entropy of binding (TS
o
bind) estimated with a nonlinear, single-binding 
site model. Values of Ka, G
o
bind, H
o
bind, and –TS
o
bind are the average of at least seven 
experiments and the uncertainties are one standard deviation from the mean. 
pKa-correction of observed ITC data: We corrected the Ka of each arylsulfonamide ligand—
to reflect the binding of the arylsulfonamide anion (ArSO2NH
–) to the zinc-bound water form of 
HCA (HCA-Zn
II-OH2
+)—using a previously reported method,
[15] which is explained in detail by 
Snyder et al.
[2] Table S2 lists the observed, and the pKa-corrected values of G
o
bind, H
o
bind, and 
–TS
o
bind for the sulfonamide ligands investigated in this study. Figure S2 shows ΔG°bind, 
ΔH°bind, and TΔS°bind as function of SASA for each ligand. 
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Table S2. Observed and pKa-corrected thermodynamic parameters for free energy of binding 
(ΔG°bind), enthalpy of binding (ΔH°bind), and entropy of binding (TΔS°bind) for the anion of each 
heteroarylsulfonamide ligand to HCA II.  
 
Ligand  N
a 
SASA 
(Å
2) 
ΔG°bind
 
(kcal mol
1) 
ΔH°bind
 
(kcal mol
1)
TΔS°bind 
(kcal mol
1)
observed  corrected
b  observed  corrected
b  observed  corrected
b 
  thiophene                
    T  6  303    9.0±0.1 12.8±0.1   9.4±0.4 11.9±0.4  0.4±0.5  0.9±0.5 
    H4BT  9  369  11.2±0.2  14.4±0.2  13.7±0.4  15.7±0.4   2.5±0.3  1.3±0.3 
    F4BT  9  380  11.3±0.2  13.9±0.2  13.2±0.6  14.5±0.6   1.9±0.5  0.7±0.5 
    H8BT  7  394  10.5±0.1  14.7±0.1  11.6±0.1  14.4±0.1   1.1±0.02 0.3±0.1
           
  thiazole               
    TA  7  296  10.0±0.1 12.3±0.1 13.9±0.2 14.7±0.2  3.8±0.3  2.5±0.3 
    H4BTA  9  364  11.4±0.3  13.5±0.3  18.6±0.6  18.8±0.6   7.1±0.8  5.3±0.8 
    F4BTA  9  379  11.3±0.2  13.0±0.2  17.3±0.6  16.3±0.6   6.0±0.5  3.4±0.5 
    H8BTA  n.d.  391  n.d.  n.d.  n.d.  n.d.   n.d.   n.d.
             
  pyrrole               
    BP  12  366  10.3±0.1  14.2±0.1  10.8±1.2  13.4±1.2    0.6±1.2  0.9±1.2 
    F4BP  13  377  10.3±0.2  13.7±0.2  8.6±1.2  10.7±1.2  1.8±1.0  3.0±1.0 
             
  N-methyl pyrrole               
    H4MBP  9  384    9.9±0.1  13.2±0.1  10.4±0.5  12.4±0.5  0.5±0.5  0.7±0.5 
    F4MBP  6  402  10.6±0.1  13.3±0.1  6.9±0.8  8.5±0.8  3.7±0.8  4.8±0.8 
           
 
a  Number of experiments used for analyses. 
b  Corrected for the pKa-values determined as described above. 
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Figure S2. The thermodynamics of binding (i.e., G
o
bind, H
o
bind, and -TS
o
bind) of the anions of 
heteroarylsulfonamide ligands to HCA as a function of the difference in solvent-accessible 
surface area between the bound and unbound states of the ligand (∆SASAunbound = ∆SASAbound + 
∆SASAprotein − ∆SASAcomplex). Each datum represents the average values of at least seven 
independent measurements (the error bars represent one standard deviation from the mean).  
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Decomposition of the Free Energy of Binding Calculations 
We calculated the binding energies of H4BTA and F4BTA using the MM-GBSA method
[16] 
(as implemented in Prime
[17, 18]). We prepared the initial crystal structure coordinates for the 
F4BTA-HCA complex with the Protein Preparation Wizard in Maestro (using the H4BTA-HCA 
complex, PDB code 3S73). The Prime MM-GBSA calculations of each complex held the 
residues of the binding pocket of HCA rigid and with an energy-minimized structure of the 
ligand. The binding energy decomposition contained the following terms: Coulombic 
interactions, van der Waals (vdW) interactions, bonded conformations (bond, angle, and torsion), 
H-bonding, lipophilic, π-π stacking, and generalized Born solvation. Each component was 
computed separately for the ligand, the empty binding pocket of HCA, and the ligand-HCA 
complex and then appropriately summed to calculate each contribution to the total binding 
energy. The anionic charge on the ligand was computed using a fit to the electrostatic potential 
derived from quantum mechanics at the RHF/6-31G* level of theory,
[19] which has been shown 
to perform well with continuum solvation models. Energy terms are shown in Table S4. 
 
Biostructural analyses 
Protein Crystallization: Monoclinic crystals of HCA were prepared with the hanging drop 
diffusion method published by McKenna and coworkers,
[3] and the crystals of HCA were left 
undisturbed (at 4 
oC) until needed for soaking experiments. 
Ligand Soaking Experiments: We soaked the crystals of HCA in saturated solutions of the 
benzo- and fluorobenzo-extended ligands using the procedure described previously.
[2] 
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Table S4. Decomposition of the Free Energy of Binding for H4BTA and F4BTA (in kcal mol
-1).  
  Coulomb  vdW  Bonded  H-bond  Lipo  Stacking  Solvation  Total 
H4BTA  –115.2  –26.3  1.2  –0.4  –15.9  0.0  113.5  –43.1 
F4BTA  –109.4  –27.5  1.3  –0.3  –15.4  0.0  105.3  –46.1 
Difference      5.8   –1.2  0.1   0.1    0.5  0.0    –8.2   –3.0 
                 
    
Page 31 of 34 
X-ray Crystallography: X-ray diffraction data of each crystal was collected at Brookhaven 
National Laboratory on the ADSC Quantum Q315 CCD detector at the National Synchrotron 
Light Source (beamline X-25) in collaboration with the Mail-Program, Brookhaven National 
Laboratory.
[20] Reflections were indexed and integrated using HKL2000, and scaled using 
SCALEPACK.
[21] 
Solution of Crystal Structures: Diffraction data were analyzed using the CCP4i suite of 
crystallography software
[22] using previously published procedures. Table S3 summarizes the 
crystallographic details for each protein-ligand structure. Figure S3 shows the images of the 
binding pocket of HCA II occupied by the various arylsulfonamide ligands used in this study. 
Only protein residues within a 5 Å distance from the ligands are shown. Figure S4 shows 
instructive overlays of crystal structures.  
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Figure S3. Occupied active site of HCA II found in crystal structure analyses of HCA 
complexed with: (A) H4BT, (B) F4BT, (C) H8BT, (D) H4BTA, (E) F4BTA, (F) H8BTA, (G) 
H4MBP, and (H) F4MBP. 
 
 
 
 
 
(D)  (E)  (F) 
(G)  (H) 
(A)  (B)  (C)  
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Figure S4. Overlays of benzo-, fluorobenzo-, and tetrahydrobenzo-extended ligands in the active 
site of HCA. Each overlay contains the crystallographically resolvable waters for: (A) H4BT and 
F4BT, (B) H4BT and H8BT, (C) H4BTA and F4BTA, (D) H4BTA and H8BTA, (E) H4MBP and 
F4MBP. The benzo-extended ligands are shown in blue, the fluorobenzo-extended ligands in red, 
and tetrahydrobenzo-extended ligands in orange. In each image, the zinc atom is represented by a 
purple sphere. We included the three histidine residues that coordinate the zinc atom to show the 
heavy-atom alignment of proteins in each overlay. 
 
 
(A)  (B) 
(C)  (D) 
(E)  
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